Indeed, EGR1 is overexpressed in certain cancers, such as prostate cancer, gastric cancer and cervical cancer (Eid et al., 1998; Akutagawa et al., 2008; Zheng et al., 2010). This evidence concerns the gene EGR1 and prostate carcinoma.